Perspective Therapeutics Inc (AMEX: CATX) kicked off on Monday, down -4.60% from the previous trading day, before settling in for the closing price of $4.35. Over the past 52 weeks, CATX has traded in a range of $2.28-$19.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 53.78%. With a float of $48.38 million, this company’s outstanding shares have now reached $67.56 million.
Let’s determine the extent of company efficiency that accounts for 119 employees. In terms of profitability, gross margin is 100.0%, operating margin of -15937.09%, and the pretax margin is -13973.89%.
Perspective Therapeutics Inc (CATX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Perspective Therapeutics Inc is 28.41%, while institutional ownership is 75.55%. The most recent insider transaction that took place on Nov 25 ’24, was worth 22,814. In this transaction Director of this company bought 6,266 shares at a rate of $3.64, taking the stock ownership to the 430,058 shares. Before that another transaction happened on Nov 25 ’24, when Company’s Chief Financial Officer bought 12,829 for $3.82, making the entire transaction worth $48,974. This insider now owns 48,800 shares in total.
Perspective Therapeutics Inc (CATX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.9 earnings per share (EPS), lower than consensus estimate (set at -0.4) by -0.5. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.78% per share during the next fiscal year.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Take a look at Perspective Therapeutics Inc’s (CATX) current performance indicators. Last quarter, stock had a quick ratio of 9.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 31.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Looking closely at Perspective Therapeutics Inc (AMEX: CATX), its last 5-days average volume was 2.96 million, which is a jump from its year-to-date volume of 0.84 million. As of the previous 9 days, the stock’s Stochastic %D was 25.69%. Additionally, its Average True Range was 0.83.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 8.89%, which indicates a significant decrease from 14.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 318.58% in the past 14 days, which was higher than the 140.11% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.60, while its 200-day Moving Average is $12.63. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $4.32. Second resistance stands at $4.49. The third major resistance level sits at $4.60. If the price goes on to break the first support level at $4.04, it is likely to go to the next support level at $3.93. Now, if the price goes above the second support level, the third support stands at $3.76.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
The company with the Market Capitalisation of 280.49 million has total of 67,588K Shares Outstanding. Its annual sales at the moment are 1,430 K in contrast with the sum of -46,510 K annual income. Company’s last quarter sales were recorded 370 K and last quarter income was -15,120 K.
